Medicalgorithmics announced today that the FDA approved its Qpatch wearable device for electrocardiogram (ECG) readings. Warsaw, Poland–based Medicalgorithmics designed the state-of-the-art, wearable device to measure individual ECG signals and obtain accurate cardiac arrhythmia diagnoses across up to 15 days of monitoring sessions. According to a news release, Medicalgorithmics’ Qpatch has been selected for a clinical […]
medicalgorithmics
HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant
Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]
